FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)

6 Months Ended

Jun. 30, 2018

Fair Value Disclosures Abstract

Schedule of recurring fair value measurements

	Fair Value Measurements At Reporting Date
			Quoted prices		Significant		Significant		Measured at
	Balance at		in active		other observable		unobservable		Net Asset Value
	June 30,		markets		inputs		inputs		as a Practical
Description	2018		Level 1		Level 2		Level 3		Expedient (2)
	(amounts in thousands)
Liabilities
Deferred compensation plan liabilities (1)	$	33,804	$	28,873	$	-	$	-	$	4,931
			Quoted prices		Significant		Significant		Measured at
	Balance at		in active		other observable		unobservable		Net Asset Value
	December 31,		markets		inputs		inputs		as a Practical
Description	2017		Level 1		Level 2		Level 3		Expedient (2)
	(amounts in thousands)
Liabilities
Deferred compensation plan liabilities (1)	$	40,995	$	23,751	$	-	$	-	$	17,244

Schedule Of Carrying Value Of Financial Instruments

	June 30,				December 31,
	2018				2017
	Carrying		Fair		Carrying		Fair
	Value		Value		Value		Value
	(amounts in thousands)
Term B Loans (1)	$	1,323,350	$	1,306,808	$	1,330,000	$	1,336,650
Revolver (2)	$	205,000	$	205,000	$	143,000	$	143,000
Senior Notes (3)	$	400,000	$	382,500	$	400,000	$	422,876
Other debt (4)	$	936			$	70
Letters of credit (4)	$	3,987			$	1,856

Schedule of Cost Method Investments Table Text Block

	Cost-Method Investments
	Carrying Amount
	June 30,		December 31,
	2018		2017
		(amounts in thousands)
Investment balance before cumulative
other than temporary impairment as of January 1,	$	9,955	$	255
Accumulated other than temporary impairment as of January 1,		-		-
Investment beginning balance after cumulative
other than temporary impairment as of January 1,		9,955		255
Acquisition of interest in a privately held company		1,250		9,700
Ending period balance	$	11,205	$	9,955